Effects of Anticoagulant Therapy and Frailty in the Elderly Patients with Atrial Fibrillation

Jiancao Ding,1 Ying Sun,2 Kan Zhang,2 Wei Huang,2 Mei Tang,2 Dai Zhang,2 Yunli Xing2 1Department of Geriatrics, First People’s Hospital of Zigong, Sichuan, People’s Republic of China; 2Department of Geriatrics, Beijing Friendship Hospital, Capital Medical University, Beijing, People’s Republic of Ch...

Full description

Bibliographic Details
Main Authors: Ding J, Sun Y, Zhang K, Huang W, Tang M, Zhang D, Xing Y
Format: Article
Language:English
Published: Dove Medical Press 2024-02-01
Series:Clinical Interventions in Aging
Subjects:
Online Access:https://www.dovepress.com/effects-of-anticoagulant-therapy-and-frailty-in-the-elderly-patients-w-peer-reviewed-fulltext-article-CIA
_version_ 1797305355341922304
author Ding J
Sun Y
Zhang K
Huang W
Tang M
Zhang D
Xing Y
author_facet Ding J
Sun Y
Zhang K
Huang W
Tang M
Zhang D
Xing Y
author_sort Ding J
collection DOAJ
description Jiancao Ding,1 Ying Sun,2 Kan Zhang,2 Wei Huang,2 Mei Tang,2 Dai Zhang,2 Yunli Xing2 1Department of Geriatrics, First People’s Hospital of Zigong, Sichuan, People’s Republic of China; 2Department of Geriatrics, Beijing Friendship Hospital, Capital Medical University, Beijing, People’s Republic of ChinaCorrespondence: Yunli Xing, Department of Geriatrics, Beijing Friendship Hospital, Capital Medical University, No. 95, Yongan Road, Xicheng District, Beijing, 100050, People’s Republic of China, Tel +86 13121181469, Fax +86 10 6313 8040, Email xingyunli1976@126.comObjective: This study explored whether anticoagulation is safe for frail and non-frail elderly patients who have nonvalvular atrial fibrillation (NVAF).Methods: At hospital discharge, the anticoagulant regimen and frailty status were recorded for 361 elderly patients (aged ≥ 75 y) with NVAF. The patients were followed for 12 months. The endpoints included occurrence of thrombosis; bleeding; all-cause death; and cardiovascular events.Results: At hospital discharge, frailty affected 50.42% of the population and the anticoagulation rate was 44.04%. At discharge, age (OR 0.948, P = 0.006), paroxysmal NVAF (OR 0.384, P < 0.001), and bleeding history (OR 0.396, P = 0.001) were associated with a decrease in rate of receiving anticoagulation, while thrombotic events during hospitalization (OR 2.281, P = 0.021) were associated with an increase. Relative to non-frail patients, those with frailty showed a higher rate of ischemic stroke (5.33% cf. 3.01%), bleeding (P = 0.006) events, and all-cause mortality (P = 0.001). Relative to the group without anticoagulation, in those with anticoagulation the rate of thrombotic events was lower (6.99 cf. 10.98%) and bleeding events were higher (20.98 cf. 12.72%), but the risk of major bleeding was comparable.Conclusion: In the elderly patients with NVAF, the decision toward anticoagulation therapy at hospital discharge was influenced by age, bleeding history, paroxysmal atrial fibrillation diagnosis, and absence of thrombosis. Frail patients were at greater risk of bleeding and all-cause mortality. Anticoagulation tended to reduce the risk of thrombotic events.Keywords: elderly, non-valvular atrial fibrillation, frailty, anticoagulation
first_indexed 2024-03-08T00:25:36Z
format Article
id doaj.art-3f35cdd1017e435484dd0b3c1bffc449
institution Directory Open Access Journal
issn 1178-1998
language English
last_indexed 2024-03-08T00:25:36Z
publishDate 2024-02-01
publisher Dove Medical Press
record_format Article
series Clinical Interventions in Aging
spelling doaj.art-3f35cdd1017e435484dd0b3c1bffc4492024-02-15T19:18:26ZengDove Medical PressClinical Interventions in Aging1178-19982024-02-01Volume 1924725490473Effects of Anticoagulant Therapy and Frailty in the Elderly Patients with Atrial FibrillationDing JSun YZhang KHuang WTang MZhang DXing YJiancao Ding,1 Ying Sun,2 Kan Zhang,2 Wei Huang,2 Mei Tang,2 Dai Zhang,2 Yunli Xing2 1Department of Geriatrics, First People’s Hospital of Zigong, Sichuan, People’s Republic of China; 2Department of Geriatrics, Beijing Friendship Hospital, Capital Medical University, Beijing, People’s Republic of ChinaCorrespondence: Yunli Xing, Department of Geriatrics, Beijing Friendship Hospital, Capital Medical University, No. 95, Yongan Road, Xicheng District, Beijing, 100050, People’s Republic of China, Tel +86 13121181469, Fax +86 10 6313 8040, Email xingyunli1976@126.comObjective: This study explored whether anticoagulation is safe for frail and non-frail elderly patients who have nonvalvular atrial fibrillation (NVAF).Methods: At hospital discharge, the anticoagulant regimen and frailty status were recorded for 361 elderly patients (aged ≥ 75 y) with NVAF. The patients were followed for 12 months. The endpoints included occurrence of thrombosis; bleeding; all-cause death; and cardiovascular events.Results: At hospital discharge, frailty affected 50.42% of the population and the anticoagulation rate was 44.04%. At discharge, age (OR 0.948, P = 0.006), paroxysmal NVAF (OR 0.384, P < 0.001), and bleeding history (OR 0.396, P = 0.001) were associated with a decrease in rate of receiving anticoagulation, while thrombotic events during hospitalization (OR 2.281, P = 0.021) were associated with an increase. Relative to non-frail patients, those with frailty showed a higher rate of ischemic stroke (5.33% cf. 3.01%), bleeding (P = 0.006) events, and all-cause mortality (P = 0.001). Relative to the group without anticoagulation, in those with anticoagulation the rate of thrombotic events was lower (6.99 cf. 10.98%) and bleeding events were higher (20.98 cf. 12.72%), but the risk of major bleeding was comparable.Conclusion: In the elderly patients with NVAF, the decision toward anticoagulation therapy at hospital discharge was influenced by age, bleeding history, paroxysmal atrial fibrillation diagnosis, and absence of thrombosis. Frail patients were at greater risk of bleeding and all-cause mortality. Anticoagulation tended to reduce the risk of thrombotic events.Keywords: elderly, non-valvular atrial fibrillation, frailty, anticoagulationhttps://www.dovepress.com/effects-of-anticoagulant-therapy-and-frailty-in-the-elderly-patients-w-peer-reviewed-fulltext-article-CIAelderlynon-valvular atrial fibrillationfrailtyanticoagulation
spellingShingle Ding J
Sun Y
Zhang K
Huang W
Tang M
Zhang D
Xing Y
Effects of Anticoagulant Therapy and Frailty in the Elderly Patients with Atrial Fibrillation
Clinical Interventions in Aging
elderly
non-valvular atrial fibrillation
frailty
anticoagulation
title Effects of Anticoagulant Therapy and Frailty in the Elderly Patients with Atrial Fibrillation
title_full Effects of Anticoagulant Therapy and Frailty in the Elderly Patients with Atrial Fibrillation
title_fullStr Effects of Anticoagulant Therapy and Frailty in the Elderly Patients with Atrial Fibrillation
title_full_unstemmed Effects of Anticoagulant Therapy and Frailty in the Elderly Patients with Atrial Fibrillation
title_short Effects of Anticoagulant Therapy and Frailty in the Elderly Patients with Atrial Fibrillation
title_sort effects of anticoagulant therapy and frailty in the elderly patients with atrial fibrillation
topic elderly
non-valvular atrial fibrillation
frailty
anticoagulation
url https://www.dovepress.com/effects-of-anticoagulant-therapy-and-frailty-in-the-elderly-patients-w-peer-reviewed-fulltext-article-CIA
work_keys_str_mv AT dingj effectsofanticoagulanttherapyandfrailtyintheelderlypatientswithatrialfibrillation
AT suny effectsofanticoagulanttherapyandfrailtyintheelderlypatientswithatrialfibrillation
AT zhangk effectsofanticoagulanttherapyandfrailtyintheelderlypatientswithatrialfibrillation
AT huangw effectsofanticoagulanttherapyandfrailtyintheelderlypatientswithatrialfibrillation
AT tangm effectsofanticoagulanttherapyandfrailtyintheelderlypatientswithatrialfibrillation
AT zhangd effectsofanticoagulanttherapyandfrailtyintheelderlypatientswithatrialfibrillation
AT xingy effectsofanticoagulanttherapyandfrailtyintheelderlypatientswithatrialfibrillation